[1] Surmacz E. Growth factor receptors as therapeutic targets:strategies to inhibit the insulin-like growth factor I receptor. Oncogene,2003,22:6589-6597. [2] Kurmasheva RT,Houqhton PJ. IGF-I mediated survival pathways in normal and malignant cells. Biochim Biophys Acta,2006,1766:1-22. [3] Allen GW,Saba C,Armstrong EA,et al. Insulin-like growth factor-I receptor signaling blockade combined with radiation. Cancer Res,2007,67:1155-1162. [4] Valerie K,Yacoub A,Hagan MP,et al. Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther,2007,6:789-801. [5] Gooch JL,Van Den Berg CL,et al. Insulin-like growth factor(IGF)-I rescues breast cancer cells from chemotherapy-induced cell death-proliferative and antiapoptotic effects. Breast Cancer Res Treat,1999,56:1-10. [6] Wu Y,Yakar S,Zhao L,et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res,2002,62:1030-1035. [7] Badzio A,Wynes MW,Dziadziuszko R,et al. Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer. J Thorac Oncol,2010,5:1905-1911. [8] Taunk NK,Goyal S,Moran MS,et al. Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy. Radiother Oncol,2010,96:204-208. [9] Riesterer O,Yang Q,Raju U,et al. Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.Int J Radiat Oncol Biol Phys,2011,79:1179-1187.